Skip to main content
. 2020 Nov 5;5(1):bvaa172. doi: 10.1210/jendso/bvaa172

Table 2.

Summary Estimates

Study Summary sensitivity Summary specificity Summary positive likelihood ratio Summary negative likelihood ratio
GAST with testosterone suppression 10% (95% CI, 1.1%-46.7%) 100% (95% CI, 0%-100%) - infinity 0.9 (95% CI, 0.714-1.086)
SOAVC (Best-case scenario) 100% (95% CI, 0%-100%) 100% (95% CI, 0.3%-100%) 12 216.53 (95% CI, −175 765 to 200 197.7) 0 (95% CI, 0-0)
SOAVC (Worst-case scenario) 100% (95% CI, 1.7%-100%) 100% (95% CI, 9%-100%) 74 480.42 (95% CI, −933 229 to 1 082 190) 0 (95% CI, −0.003 to 0.004)

Abbreviations: GAST, GnRH analogue stimulation test; SOAVC, selective ovarian and adrenal vein catheterization.